Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease

Journal of Psychosomatic Research

Volumn 62, Issue 4, 2007, Pages 463-467

  Carney, Robert M ^a   Freedland, Kenneth E ^a   Stein, Phyllis K ^a   Miller, Gregory E ^b   Steinmeyer, Brian ^a   Rich, Michael W ^a   Duntley, Stephen P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autonomic nervous system; Coagulation; Depression; Heart disease; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD CLOTTING; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART RATE VARIABILITY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; PROTEIN DETERMINATION;

AGED; AUTONOMIC NERVOUS SYSTEM; C-REACTIVE PROTEIN; CORONARY DISEASE; DEPRESSION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOGEN; HEART RATE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; STATISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947323766     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.12.004     Document Type: Article

References (30)

1. Glassman A., and Shapiro P. Depression and the course of coronary artery disease. Am J Psychiatry 155 (1998) 4-111
2. Carney R., and Freedland K. Depression, mortality and medical morbidity, in patients with coronary heart disease. Biol Psychiatry 54 (2003) 241-247
3. Barth J., Schumacher M., and Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66 (2004) 802-813
4. Van Melle J., de Jonge P., Spijkerman T., Tijssen J., Ormel J., van Veldhuisen D., van den Brink R., and van den Berg M. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66 (2004) 814-822
5. Carney R., Freedland K., Miller G., and Jaffe A. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 53 (2002) 897-902
6. Carney R., Freedland K., Rich M., and Jaffe A. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms. Ann Behav Med 17 (1995) 142-149
7. Maes M., Meltzer H., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., and Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
8. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., and Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
9. Dentino A., Pieper C., Rao K., Currie M., Harris T., Blazer D., and Cohen H. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47 (1999) 6-11
10. Miller G., Stetler C., Carney R., Freedland K., and Banks W. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90 (2003) 1279-1283
11. Von Kanel R., Mills P., Fainman C., and Dimsdale J. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 63 (2001) 531-544
12. Task Force of the European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Circulation 93 (1996) 1043-1065
13. März P., Cheng J., Gadient R., Patterson P., Stoyan T., Otten U., and Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A 95 (1998) 3251-3256
14. Tracey K. The inflammatory reflex. Nature 420 (2002) 853-859
15. Pavlov V., and Tracey K. The cholinergic anti-inflammatory pathway. Brain Behav Immun 19 (2005) 493-499
16. Aronson D., Mittleman M., and Burger A. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12 (2001) 294-300
17. Malave H., Taylor A., Nattama J., Deswal A., and Mann D. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123 (2003) 716-724
18. Lanza G., Sgueglia G., Cianflone D., Rebuzzi A., Angeloni G., Sestito A., Infusino F., Crea F., Maseri A., and for the SPAI (Stratificazione Prognostica dell' Angina Instabile) Investigators. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 97 (2006) 1702-1706
19. Carney R., Howells W., Freedland K., Duntley S., Stein P., Rich M., and Miller G. Depression and obstructive sleep apnea in patients with coronary heart disease. Psychosom Med 68 (2006) 443-448
20. Freedland K., Skala J., Carney R., Raczynski J., Taylor C., Mendes de Leon C., Ironson G., Youngblood M., Krishnan K., Veith R., and for the ENRICHD Investigators. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 64 (2002) 897-905
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition, revised) (1994), The American Psychiatric Association, Washington DC
22. Rottman J., Steinman R., and Albrecht P. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol 66 (1990) 1522-1524
23. Berliner A., Navab M., Fogelman A., Frank J., Demer L., Edwards P., Watson A., and Lusis A. Atherosclerosis: basic mechanisms. Circulation 91 (1995) 2488-2496
24. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
25. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 279 (1998) 1477-1482
26. Rechtschaffen A., and Kales A. Manual of standardized terminology, techniques and scoring system for sleep stages of human subjects (1968), UCLA Brain Information Service/Brain Research Institute, Los Angeles
27. Bigger J., Fleiss J., Steinman R., Rolnitzky L., Schneider W., and Stein P. RR variability in healthy, middle aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 91 (1995) 1936-1943
28. Sinzinger H., and Pirich C. Platelet function and fibrinogen. In: Ernst E., Koenig W., Lowe G., and Meade T. (Eds). Fibrinogen: a "new" cardiovascular risk factor (1992), Blackwell-MZV, Vienna, Austria 46-50
29. Thompson W., Stirk C., and Smith E. Fibrin degradation products as the pathological growth stimulus to atherosclerotic plaque formation. In: Ernst E., Koenig W., Lowe G., and Meade T. (Eds). Fibrinogen: a "new" cardiovascular risk factor (1992), Blackwell-MZV, Vienna, Austria 35-40
30. Taylor J., Carr D., Myers C., and Eckberg D. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 98 (1998) 547-555